Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 39: 1804-1810, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jay, D. W.
Right arrow Articles by Provasek, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jay, D. W.
Right arrow Articles by Provasek, D.

Clinical Chemistry, Vol 39, 1804-1810, Copyright © 1993 by American Association for Clinical Chemistry

Characterization and mathematical correction of hemolysis interference in selected Hitachi 717 assays

DW Jay and D Provasek
Department of Pathology and Laboratory Medicine, Texas A&M University College of Medicine, Temple.

The effect of hemolysis on several assays performed with the Hitachi 717 was quantified by relating the amount of error to the concentration of hemoglobin. Hemolysis interference was judged clinically significant when analyte concentration varied by > 10% from the initial value. Hemolysis interference was significant for alkaline phosphatase, aspartate aminotransferase, alpha-amylase, bilirubin, creatine kinase, gamma-glutamyltransferase, lactate dehydrogenase, lactate dehydrogenase- 1, potassium, and theophylline assays. Error (expressed in absolute terms) was linearly dependent on hemoglobin concentration and independent of the initial analyte concentration in each case, except for bilirubin and theophylline, where multiple regression analysis was required to quantify the effect. Relative error was dependent on the initial analyte concentration in all cases. Correction formulas were calculated from linear regression of absolute error vs hemoglobin concentration. Clinical application of correction formulas and mechanisms of hemolysis interference for each assay are discussed.


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
F. M. Yilmaz and D. Yucel
Effect of Addition of Hemolysate on Urine and Cerebrospinal Fluid Assays for Protein
Clin. Chem., January 1, 2006; 52(1): 152 - 153.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
H. J. Vermeer, E. Thomassen, and N. de Jonge
Automated Processing of Serum Indices Used for Interference Detection by the Laboratory Information System
Clin. Chem., January 1, 2005; 51(1): 244 - 247.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Gay-Bellile, D. Bengoufa, P. Houze, D. Le Carrer, M. Benlakehal, B. Bousquet, B. Gourmel, and T. Le Bricon
Automated Multicapillary Electrophoresis for Analysis of Human Serum Proteins
Clin. Chem., November 1, 2003; 49(11): 1909 - 1915.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Hawkins
Variability in Potassium/Hemoglobin Ratios for Hemolysis Correction
Clin. Chem., May 1, 2002; 48(5): 796 - 796.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
S. C. Kazmierczak, P. G. Catrou, and D. Boudreau
Simplified interpretative format for assessing test interference: studies with hemoglobin-based oxygen carrier solutions
Clin. Chem., November 1, 1998; 44(11): 2347 - 2352.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. C. Y. Ali, C. C. Mihas, and J. A. Campbell
Interferences of o-raffinose cross-linked hemoglobin in three methods for serum creatinine
Clin. Chem., September 1, 1997; 43(9): 1738 - 1743.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. C. Y. Ali and J. A. Campbell
Interference of o-Raffinose Cross-Linked Hemoglobin with Routine Hitachi 717 Assays
Clin. Chem., September 1, 1997; 43(9): 1794 - 1796.
[Full Text]


Home page
Clin. Chem.Home page
C. M. Balion, P. A. Champagne, and A. C. Y. Ali
Evaluation of HemogloBindTM for Removal of o-Raffinose Cross-Linked Hemoglobin (HemolinkTM) from Serum
Clin. Chem., September 1, 1997; 43(9): 1796 - 1798.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.